[HTML][HTML] Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene-and …
Journal of clinical oncology, 2010•ncbi.nlm.nih.gov
Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal
De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression
Signatures: A Cancer and Leukemia Group B Study - PMC Back to Top Skip to main content
NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main
Navigation Search PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal
List J Clin Oncol PMC2815994 Other Formats PDF (625K) Actions Cite Collections Share …
De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression
Signatures: A Cancer and Leukemia Group B Study - PMC Back to Top Skip to main content
NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main
Navigation Search PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal
List J Clin Oncol PMC2815994 Other Formats PDF (625K) Actions Cite Collections Share …
Abstract
Purpose
To analyze the prognostic significance of NPM1 mutations, and the associated gene-and microRNA-expression signatures in older patients with de novo, cytogenetically normal acute myeloid leukemia (CN-AML) treated with intensive chemotherapy.
ncbi.nlm.nih.gov